Oncology Institute, Inc. (TOI) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$15.72M | -538.0% |
| 2024 | $3.59M | -93.7% |
| 2023 | $57.02M | -53.7% |
| 2022 | $123.17M | +18.3% |
| 2021 | $104.16M | +270.7% |
| 2020 | $28.10M | -33.4% |
| 2019 | $42.22M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$15.72M | -538.0% |
| 2024 | $3.59M | -93.7% |
| 2023 | $57.02M | -53.7% |
| 2022 | $123.17M | +18.3% |
| 2021 | $104.16M | +270.7% |
| 2020 | $28.10M | -33.4% |
| 2019 | $42.22M | — |